The Ingenuity Lab will advance innovative research and development in the areas of materials, diagnostic devices and therapeutic applications in orthopaedics. Among other things, the team is working on new tissue bonding technologies for minimally invasive and robot-assisted surgery. Surgical adhesives with integrated sensors are to be used to detect infections and other complications at an early stage. Another focus of the Ingenuity Lab is research into new treatment methods for radiation-resistant soft tissue tumors and antimicrobial resistance.

Under the leadership of Inge Herrmann, the lab's research groups will work closely with the clinical teams at Balgrist University Hospital as well as with research groups at Empa and ETH Zurich to develop technology-based solutions that are directly tailored to the greatest medical challenges. Inge Hermann: "Our vision for the Ingenuity Lab is to develop novel solutions that directly address the most urgent needs of MDs, nurses and patients. In doing so, we want to push the boundaries of medical technology. The combination of clinical excellence and innovative research is crucial to developing the next generation of medical solutions. The Ingenuity Lab aims to harness these synergies and provides a platform where scientists, engineers and physicians can work together to shape the medicine and medical technology of tomorrow."

Balgrist University Hospital is renowned for its outstanding patient care and its commitment to medical research and education. With the opening of the Ingenuity Lab, a few months after the OR-X, the clinic will further strengthen its position as one of the leading centers for orthopaedic research and treatment in Europe. "We are delighted to welcome Inge Herrmann and the Ingenuity Lab to Balgrist. This partnership underlines our commitment to innovation and excellence in musculoskeletal medicine," says Mazda Farshad, Balgrist University Hospital's Medical Director.